Skip to main content
. 2017 Sep 21;7:12044. doi: 10.1038/s41598-017-08070-2

Figure 6.

Figure 6

The effects of BAY 60-7550 on Aβ-induced changes in IL-17 and IL-22 expression. IL-22 and IL-17 expression after BAY (i.c.v.) treatment was tested in the cortex (A,B) and in the hippocampus (C,D) of mice (mean ± SEM, n = 10). **p < 0.01, ***p < 0.001, vs vehicle-treated control group. #p < 0.05, ##p < 0.01, vs vehicle-treated Aβ group. $p < 0.05, vs BAY (10 μg)-treated Aβ group.